Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page; Removed the older funding notice (v3.4.1). These changes do not modify the study content, eligibility, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:13:26.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and an update from version v3.4.0 to v3.4.1 was added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:06:57.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and makes minor label/capitalization updates, along with a revision indicator (v3.4.0) replacing the prior version (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:58:52.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:07:52.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Kansas, New York, and Texas sites; removed the separate California/Kansas/New York/Texas location entries and the HHS Vulnerability Disclosure link; updated the page revision to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T10:22:08.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page shows a new revision label: v3.3.2 replacing v3.3.1, a minor technical update that does not affect the study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:40:17.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.